A Research Study for Latina Women After Breast Cancer Treatment

Inclusion Criteria:

1. Female
2. Diagnosis of breast cancer, non-metastatic, stage 0-IIIA; for women diagnosed with stage 0, either radiation or chemotherapy is required as an additional treatment to surgery
3. Completed active treatment for breast cancer (surgery, chemotherapy and/or radiation therapy, current hormonal treatment allowed)
4. No current evidence of disease
5. Within 3 to 24 months post-active treatment \[e.g., surgery, chemotherapy, radiation, or combination of the two or three\]
6. at least 21 years of age
7. Able to speak and read English or Spanish
8. Able to provide informed consent
9. Elevated score on breast cancer symptom burden and HRQoL, measured by the Functional Assessment of Cancer Therapy-Breast using an established cut-off score for clinically meaningful, compromised HRQoL
10. Self-identified Hispanic/Latina ethnicity.

Exclusion Criteria:

1. Visual, hearing, voice, or motor impairment that would prevent completion of study procedures
2. diagnosis of an unmanaged psychotic disorder, bipolar disorder, dissociative disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous - this includes patients who have life-threatening illness (e.g., end-stage kidney disease) or diagnosis of a chronic disease that is associated with a major functional impairment (e.g., fibromyalgia)
3. Illicit substance or alcohol dependence
4. Suicidal ideation, plan, intent
5. Alzheimer's, dementia or history of stroke
6. Scheduled reconstruction surgery within 1 month of any study procedures or involvement.